Global Mapping of Potentially Inappropriate Prescribing for Older Adults in Community Settings: An Umbrella Review
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Potentially inappropriate prescribing (PIP) is a major public health concern with several undesirable health conse-quences for older adults. In this overview, we aimed to map and gather information from existing literature to pro-vide a better insight into the prevalence of PIP among community dwellers. Electronic databases were searched from their inception to April 2022. The quality of the included systematic reviews (SRs) was assessed using the as-sessment of multiple systematic reviews checklist. The degree of overlap within the SRs was also evaluated (2% overlap). All SRs on the prevalence of PIP in older individuals in community settings were included, and a narrative approach was used to synthesize data. Nineteen SRs comprising 548 primary studies met the inclusion criteria, and the average quality of the included SRs was moderate. More than half (50.5%) of the primary studies were conduct-ed in Europe, followed by the United States (22.8%), and Asia (18.9%). Thirty different criteria were used in the pri-mary studies to estimate the prevalence of PIP. The most widely used criteria were those presented in Beers (41.8%) and STOPP (Screening Tool of Older Persons’ Prescriptions)/START (Screening Tool to Alert to Right Treatment) (21.8%) criteria. Benzodiazepines, nonsteroidal anti-inflammatory drugs, and antidepressants were the most fre-quently reported PIPs. A considerable variation in the prevalence of PIP ranging from 0% to 98% was reported by SRs. However, there is a high degree of uncertainty regarding the extent of PIP in community settings. To identify knowledge-to-action gaps, SR authors should consider the differences in prevalence of PIP according to settings, applied tools, data sources, geographical areas, and specific pathologies. There is also a need for primary and SR studies from low- and middle-income countries regarding the prevalence of PIP.
Abstract
Potentially inappropriate prescribing (PIP) is a major public health concern with several undesirable health conse-quences for older adults. In this overview, we aimed to map and gather information from existing literature to pro-vide a better insight into the prevalence of PIP among community dwellers. Electronic databases were searched from their inception to April 2022. The quality of the included systematic reviews (SRs) was assessed using the as-sessment of multiple systematic reviews checklist. The degree of overlap within the SRs was also evaluated (2% overlap). All SRs on the prevalence of PIP in older individuals in community settings were included, and a narrative approach was used to synthesize data. Nineteen SRs comprising 548 primary studies met the inclusion criteria, and the average quality of the included SRs was moderate. More than half (50.5%) of the primary studies were conduct-ed in Europe, followed by the United States (22.8%), and Asia (18.9%). Thirty different criteria were used in the pri-mary studies to estimate the prevalence of PIP. The most widely used criteria were those presented in Beers (41.8%) and STOPP (Screening Tool of Older Persons’ Prescriptions)/START (Screening Tool to Alert to Right Treatment) (21.8%) criteria. Benzodiazepines, nonsteroidal anti-inflammatory drugs, and antidepressants were the most fre-quently reported PIPs. A considerable variation in the prevalence of PIP ranging from 0% to 98% was reported by SRs. However, there is a high degree of uncertainty regarding the extent of PIP in community settings. To identify knowledge-to-action gaps, SR authors should consider the differences in prevalence of PIP according to settings, applied tools, data sources, geographical areas, and specific pathologies. There is also a need for primary and SR studies from low- and middle-income countries regarding the prevalence of PIP.
참고문헌 (48)
- Marengoni A, "Aging with multimorbidity : a systematic review of the literature", Ageing Res Rev, 10, pp.430~439 (2011)
- Gallagher P, "Inappropriate prescribing in the elderly", J Clin Pharm Ther, 32, pp.113~121 (2007)
- Mekonnen AB, "Potentially inappropriate prescribing and its associations with health-related and systemrelated outcomes in hospitalised older adults : a systematic review and meta-analysis", Br J Clin Pharmacol, 87, pp.4150~4172 (2021)
- Murillo-Munoz MM, "Potential prescribing omissions in patients with cardiovascular disease", Int J Clin Pract, 73, pp.e13428~ (2019)
- Tommelein E, "Potentially inappropriate prescribing in community-dwelling older people across Europe : a systematic literature review", Eur J Clin Pharmacol, 71, pp.1415~1427 (2015)
- Redston MR, "Prevalence of potentially inappropriate medication use in older inpatients with and without cognitive impairment : a systematic review", J Alzheimers Dis, 61, pp.1639~1652 (2018)
- Cabre M, "Avoidable hospitalizations due to adverse drug reactions in an acute geriatric unit : analysis of 3, 292 patients", Med Clin(Barc), 150, pp.209~214 (2018)
- Reich O, "Potentially inappropriate medication use in older patients in Swiss managed care plans : prevalence, determinants and association with hospitalization", PLoS One, 9, pp.e105425~ (2014)
- Klarin I, "The association of inappropriate drug use with hospitalisation and mortality : a population-based study of the very old", Drugs Aging, 22, pp.69~82 (2005)
- Motter FR, "Potentially inappropriate medication in the elderly : a systematic review of validated explicit criteria", Eur J Clin Pharmacol, 74, pp.679~700 (2018)
- Liew TM, "The prevalence and impact of potentially inappropriate prescribing among older persons in primary care settings : multilevel meta-analysis", Age Ageing, 49, pp.570~579 (2020)
- Bories M, "Drug-drug interactions in elderly patients with potentially inappropriate medications in primary care, nursing home and hospital settings : a systematic review and a preliminary study", Pharmaceutics, 13, pp.266~ (2021)
- Liu GG, "The continuing challenge of inappropriate prescribing in the elderly : an update of the evidence", J Am Pharm Assoc(Wash), 42, pp.847~857 (2002)
- Thomas RE, "Assessing medication problems in those ≥ 65 using the STOPP and START criteria", Curr Aging Sci, 9, pp.150~158 (2016)
- Aromataris E, "Summarizing systematic reviews : methodological development, conduct and reporting of an umbrella review approach", Int J Evid Based Healthc, 13, pp.132~140 (2015)
- Shea BJ, "Development of AMSTAR : a measurement tool to assess the methodological quality of systematic reviews", BMC Med Res Methodol, 7, pp.10~ (2007)
- Munn Z, "What kind of systematic review should I conduct? : a proposed typology and guidance for systematic reviewers in the medical and health sciences", BMC Med Res Methodol, 18, pp.5~ (2018)
- Jokanovic N, "Pharmacist-led medication review in community settings : an overview of systematic reviews", Res Social Adm Pharm, 13, pp.661~685 (2017)
- Pieper D, "Systematic review found AMSTAR, but not R(evised)-AMSTAR, to have good measurement properties", J Clin Epidemiol, 68, pp.574~583 (2015)
- Gates M, "Quality and risk of bias appraisals of systematic reviews are inconsistent across reviewers and centers", J Clin Epidemiol, 125, pp.9~15 (2020)
- Pieper D, "Systematic review finds overlapping reviews were not mentioned in every other overview", J Clin Epidemiol, 67, pp.368~375 (2014)
- Opondo D, "Inappropriateness of medication prescriptions to elderly patients in the primary care setting : a systematic review", PLoS One, 7, pp.e43617~ (2012)
- Hill-Taylor B, "Application of the STOPP", START criteria : a systematic review of the prevalence of potentially inappropriate prescribing in older adults, and evidence of clinical, humanistic and economic impact, 2013, pp.38, 360~372
- Guaraldo L, "Inappropriate medication use among the elderly : a systematic review of administrative databases", BMC Geriatr, 11, pp.79~ (2011)
- Elmstahl S, "Polypharmacy and inappropriate drug use among older people : a systematic review", Healthy Aging Clin Care Elder, 5, pp.1~8 (2013)
- Bhagavathula AS, "Prevalence of polypharmacy, hyperpolypharmacy and potentially inappropriate medication use in older adults in India : a systematic review and meta-analysis", Front Pharmacol, 12, pp.685518~ (2021)
- Bhagavathula AS, "Prevalence of polypharmacy and risks of potentially inappropriate medication use in the older population in a developing country : a systematic review and meta-analysis", Gerontology, 68, pp.136~145 (2022)
- Chang CT, "Prevalence of drug-related problems and complementary and alternative medicine use in malaysia : a systematic review and meta-analysis of 37, 249 older adults", Pharmaceuticals(Basel), 14, pp.187~ (2021)
- Malakouti SK, "A systematic review of potentially inappropriate medications use and related costs among the elderly", Value Health Reg Issues, 25, pp.172~179 (2021)
- Thomas RE, "A systematic review of studies of the STOPP", START 2015 and American Geriatric Society Beers 2015 criteria in patients ≥ 65 years, 2019, pp.12, 121~154
- Ude-Okeleke RC, "Medicines related problems(MRPs)originating in primary care settings in older adults : a systematic review", J Pharm Pract, 36, pp.357~369 (2023)
- Muhlack DC, "The association of potentially inappropriate medication at older age with cardiovascular events and overall mortality : a systematic review and meta-analysis of cohort studies", J Am Med Dir Assoc, 18, pp.211~220 (2017)
- Nothelle SK, "Factors associated with potentially inappropriate medication use in communitydwelling older adults in the United States : a systematic review", Int J Pharm Pract, 27, pp.408~423 (2019)
- Weeda ER, "Association between potentially inappropriate medications and hospital encounters among older adults : a meta-analysis", Drugs Aging, 37, pp.529~537 (2020)
- Xu Z, "Factors associated with potentially inappropriate prescriptions and barriers to medicines optimization among older adults in primary care settings : a systematic review", Fam Med Community Health, 9, pp.e001325~ (2021)
- By the 2019 American Geriatrics Society Beers Criteria(R)Update Expert Panel, "American Geriatrics Society 2019 updated AGS Beers Criteria(R)for potentially inappropriate medication use in older adults", J Am Geriatr Soc, 67, pp.674~694 (2019)
- Moriarty F, "Comparing potentially inappropriate prescribing tools and their association with patient outcomes", J Am Geriatr Soc, 68, pp.526~534 (2020)
- Morin L, "Prevalence of potentially inappropriate medication use in older adults living in nursing homes : a systematic review", J Am Med Dir Assoc, 862, pp.e1~e9 (2016)
- Zhang Y, "Geographic variation in the quality of prescribing", N Engl J Med, 363, pp.1985~1988 (2010)
- Smeets HM, "Routine health insurance data for scientific research : potential and limitations of the Agis Health Database", J Clin Epidemiol, 64, pp.424~430 (2011)
- Tora H, "Potential drug related problems detected by electronic expert support system in patients with multi-dose drug dispensing", Int J Clin Pharm, 36, pp.943~952 (2014)
- Haidich AB, "Meta-analysis in medical research", Hippokratia, 14(Suppl 1), pp.29~37 (2010)
- Greco T, "Meta-analysis : pitfalls and hints", Heart Lung Vessel, 5, pp.219~225 (2013)
- da Costa BR, "Uses and misuses of the STROBE statement : bibliographic study", BMJ Open, 1, pp.e000048~ (2011)
- Borges Migliavaca C, "How are systematic reviews of prevalence conducted? : a methodological study", BMC Med Res Methodol, 20, pp.96~ (2020)
- Gagnon ME, "Potentially inappropriate medications in older individuals with diabetes : a population-based study in Quebec, Canada", Prim Care Diabetes, 14, pp.529~537 (2020)
- Pieper D, "Overviews of reviews often have limited rigor : a systematic review", J Clin Epidemiol, 65, pp.1267~1273 (2012)
- Lunny C, "Toward a comprehensive evidence map of overview of systematic review methods : paper 2-risk of bias assessment; synthesis, presentation and summary of the findings; and assessment of the certainty of the evidence", Syst Rev, 7, pp.159~ (2018)